共 22 条
- [21] Adoptive donor T-cell infusions are necessary and efficient to induce lasting molecular remissions after highly purified CD34+sibling donor transplants for first chronic phase chronic myeloid leukemia - Final report and long-term follow-up of a phase II study. BLOOD, 2006, 108 (11) : 856A - 856A
- [22] Long Term Follow-up of International Randomised Phase 3 Study of Rituximab Versus a Watch and Wait Approach for Patients with Asymptomatic, Low Tumour Burden Follicular Lymphoma Shows Rituximab Is Highly Effective at Delaying Time to New Treatment without Detrimental Impact Following Next Line of Therapy BLOOD, 2022, 140 : 1456 - 1458